Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human TrialsMindMed Reports Full Year 2022 Financial Results and Business HighlightsCybin to Participate in the Oppenheimer 33rd Annual Healthcare ConferenceNuminus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023Irwin Naturals Signs Letter of Intent to Acquire Braxia ScientificNuminus Wellness Inc. Reports Q1 2023 ResultsIrwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical CompanNuminus Develops Mushroom Tea for Use in Psychedelic ResearchIs the Psychedelic Sector Poised for a Comeback?!?PSYC + Nucleus Form New Partnership to Develop and Launch Psychedelic FinderWhat You Need to Know About Numinus Wellness…Numinus provides update on acquisition integration and announces new client financing optionsPSYC Corp’s Psychedelic Spotlight Surpasses One Million Page Views for Fourth Consecutive MonthNuminus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022The Psychedelic Sector is Quietly Outperforming the S&P 500PSYC Completes and Publishes 2021 Audited Financials; Will Begin Audit of Q1 & Q2 2022Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022PSYC’s Bonfire Platform Development Progresses; Will Host Free Virtual Community Event on August 29th

Canada: The Next Frontier For Medical Marijuana

Feb 20, 2015 • 3:16 PM EST
2 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

The United States cannabis industry has been one of the hottest places to invest over the last year; Canada, however, has not been too far behind. One the most important developments during 2014 was the implementation of the new federal medical marijuana program in Canada, Marihuana for Medical Purposes Regulations (MMPR). The program has enabled the country to move from a system that allowed patients to buy from a single government‐approved grower or to either grow their own or purchase from non‐commercial growers, to a system of multiple commercial providers. The Canadian medical marijuana market differs significantly from the United States market in many ways and these differences cause the licensed producers to face many challenges. These differences include:

  1. All orders are sent to patients through the mail.
  2. The system excludes concentrates and extractions.
  3. No storefronts which therefore excludes face to face ordering.
  4. They spell marijuana a different way: marihuana.
  5. They have a set of regulations called MMPR.
  6. Health Canada is responsible for approving/disapproving licenses.
  7. Licensed producers must go through an annual license renewal process.

Current size of medical marijuana patients

Currently, Health Canada estimates that there are roughly 40,000 qualified medical marijuana patients in Canada. 

What is MMPR?

The medical cannabis landscape in Canada went through significant changes during 2014. New regulations took effect on April 1, 2014, and were referred to as Marihuana for Medical Purposes Regulations (MMPR). Before that, medical marijuana patients could access medical marijuana through the Marihuana Medical Access Regulations (MMAR) program, which allowed patients to grow marijuana, designate a third party to grow marijuana for them, or obtain marijuana directly from Health Canada. Under the MMPR, patients must access medical marijuana through a Health Canada-approved Licensed Producer.

Below are two lists of licensed producers. The first is a list of producers who may sell marijuana under the MMPR. The second is a list of licensed producers who can produce, but not sell marijuana.

Fully Authorized Licensed Producers

  • Aphria
  • Bedrocan Canada Inc.
  • Broken Coast Cannabis Ltd.
  • Canna Farms Ltd.       
  • CanniMed Ltd.
  • CannTrust Inc.
  • Delta 9 Bio-Tech Inc. 
  • In The Zone Produce Ltd.
  • MariCann Inc.
  • MedReleaf Corp.
  • Mettrum Ltd.
  • OrganiGram Inc.
  •  The Peace Naturals Project Inc
  • Tilray
  • Tweed Inc.
  • Whistler Medical Marijuana Corp.

Licensed Producer – Cultivation only

  • ABcann Medicinals Inc.
  • Agripharm Corp.
  • Aurora Cannabis Enterprises Inc.
  • Bedrocan Canada Inc. (second site)
  • CannTrust Inc.
  • Hydropothicaire /Hydropothecary
  • Prairie Plant Systems Inc.
  • RedeCan Pharm
  • Thunderbird Biomedical Inc.
  • Tweed Farms Inc. 
Share Share - Facebook Share - Twitter


Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.


Top Stories

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.